Torsten Fahrig
Financieel Directeur/CFO bij RESprotect GmbH
Oorsprong van het eerstegraads netwerk van Torsten Fahrig
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
RESprotect GmbH
 RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany.
9
| Holding Company | Pharmaceuticals: Other | 9 |
UroTiss GmbH
 UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany.
3
| Subsidiary | Medical/Nursing Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Torsten Fahrig via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree Undergraduate Degree | |
| California State University-Los Angeles | College/University | Corporate Officer/Principal | |
| PROPANC BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Bonn | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
| Duitsland | 3 |
| Verenigde Staten | 2 |
| Australië | 2 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
Operationeel
| Corporate Officer/Principal | 7 |
| Chief Tech/Sci/R&D Officer | 4 |
| Chief Executive Officer | 3 |
| Founder | 3 |
| President | 1 |
Sterkste connecties
- Beurs
- Insiders
- Torsten Fahrig
- Bedrijfsconnecties
